2019
DOI: 10.21037/qims.2019.03.14
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound imaging in nonalcoholic liver disease: current applications and future developments

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
20
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 22 publications
(21 citation statements)
references
References 41 publications
1
20
0
Order By: Relevance
“…Although MR-based fat quantification is currently accepted as the noninvasive reference standard for hepatic fat quantification [ 9 30 ], it is limited by its high cost and limited accessibility. We believe that US-based technologies such as QUS may be a promising first-line tool for assessing hepatic steatosis in patients with NAFLD [ 14 ]. Our results suggest the potential application of AC-TAI and SC-TSI for screening for hepatic steatosis in patients with clinically suspected NAFLD.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although MR-based fat quantification is currently accepted as the noninvasive reference standard for hepatic fat quantification [ 9 30 ], it is limited by its high cost and limited accessibility. We believe that US-based technologies such as QUS may be a promising first-line tool for assessing hepatic steatosis in patients with NAFLD [ 14 ]. Our results suggest the potential application of AC-TAI and SC-TSI for screening for hepatic steatosis in patients with clinically suspected NAFLD.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, quantitative US (QUS) techniques from RF data analysis have been proposed as noninvasive and objective tools for the detection and grading of hepatic steatosis. In recent years, various QUS techniques using non-image-based parameters, including speed of sound, US attenuation, backscatter coefficient, and shear-wave dispersion, have been proposed for assessing hepatic steatosis, and they have shown a significant correlation with hepatic steatosis [ 10 12 13 14 ]. In our previous study, we demonstrated that two QUS techniques (tissue attenuation imaging [TAI] and tissue scatter-distribution imaging [TSI]) showed good diagnostic performance for detecting hepatic steatosis in patients with chronic liver disease [ 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…Thus, it is vital that the diagnosis and differentiation of primary lesions of liver metastases take place early to guide informed decision making. Recently, substantial advances in radiologic technology (ie, CT, MRI, and US) have significantly improved the ability to diagnose liver nodules using imaging; in particular, the liver is a focus of interest in abdominal imaging 41,42 . When hepatic metastatic lesions are detected on imaging in a timely manner, a number of treatment options are available, such as hepatic resection, hepatic artery infusion chemotherapy, and radiofrequency and microwave ablation 43,44 .…”
Section: Discussionmentioning
confidence: 99%
“…The QDI may be a promising modality for use in clinical surveillance, epidemiology research, and metabolic function evaluation in patients with NAFLD. Some quantitative analysis approaches have also been used for the diagnosis of hepatic steatosis and demonstrated to correlate with several MetS components, such as controlled attenuation parameter, acoustic structure quantification, Kurtosis coefficient, and entropy 5154 . These approaches reflect different physical properties of the liver to characterize liver tissue microstructure 55 .…”
Section: Discussionmentioning
confidence: 99%